OnconexLung Cancer (Germline)

Understanding OnconexLung Cancer (Germline)

Lung cancer is the leading cause of global cancer incidence and mortality, accounting for an estimated 2 million diagnoses and 1.8 million deaths. For diagnosis, lung cancers are classified into two main histological types - small cell lung cancer ( SCLC ) and non-small cell lung cancer (NSCLC), that are based on the appearance of the neoplastic cells under a microscope. NSCLC accounts for more than 80% of all lung cancer cases and includes non-squamous cell carcinoma- large-cell carcinoma and adenocarcinoma, and s...

What does OnconexLung Cancer (Germline) measure?

The OnconexLung Cancer (Germline) test is a comprehensive Next Generation Sequencing (NGS) assay targeting 100 genes associated with lung cancers, providing detailed genetic insights to guide targeted therapy and improve patient outcomes.

The OnconexLung Cancer (Germline) test offers insights into the molecular underpinnings of tumor mutation genes, facilitating the identification of novel genetic aberrations and potential therapeutic targets. As targeted therapies become the new standard of care in oncology, the O...